Telehealth and Telemedicine Market - Global Forecast to 2031
遠隔医療(テレヘルス&テレメディシン)市場:機能(遠隔診療、遠隔患者モニタリング(RPM)、診断・治療、分析、管理業務)、用途(遠隔ICU、遠隔放射線診断、遠隔心臓診断、糖尿病管理)、エンドユーザー(病院、外来手術センター、医療保険者)、地域別 ― 2031年までの世界予測
Telehealth and Telemedicine Market by Function (Teleconsultation, RPM, Diagnostics & Treatment, Analytics, Administrative), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), End User (Hospital, ASC, Payer), & Region - Global Forecast to 2031
| 出版 | MarketsandMarkets |
| 出版年月 | 2026年09月 |
| ページ数 | 481 |
| 図表数 | 590 |
| 価格 | 記載以外のライセンスについてはお問合せください |
| シングルユーザ | USD 4,950 |
| 種別 | 英文調査報告書 |
| 商品番号 | SMR-6869 |
遠隔医療(テレヘルス&テレメディシン)市場は、2026年の1188億米ドルから、2031年には1989億米ドルに成長し、2026年から2031年にかけての年平均成長率(CAGR)は10.9%に達するとMarketsandMarketsでは予測しています。同市場は力強く拡大しており、その主な要因として、高齢者人口の増加や、特に地方・遠隔地における医療サービスが十分に行き届いていない人々の存在、慢性疾患の有病率の上昇、そして医師をはじめとする医療従事者の慢性的な不足を背景とした、医療へのアクセスに対するニーズの高まりが挙げられます。さらに、通信インフラの進歩、スマートフォンやインターネットの普及拡大、クラウド型ヘルスケアプラットフォームの登場、そして遠隔患者モニタリング(RPM)システムの導入拡大が、市場の成長をさらに後押ししています。また、AIを活用した医療機器、デジタルヘルスプラットフォーム、オンライン診療の統合が進むことで、遠隔医療提供の拡張性と効率性も向上しています。医療提供者、医療費支払者、およびテクノロジー企業は、医療へのアクセス改善、継続的な疾患管理の支援、不必要な通院の削減、そしてより個別化された患者エンゲージメントの実現を目指し、遠隔医療ソリューションの導入を加速させています。一方で、地域ごとに異なる規制、医療システム内における不正や悪用への懸念、データプライバシーやサイバーセキュリティのリスク、システム間の相互運用性に関する課題、さらには新しい技術の導入に対する心理的な抵抗感などが、予測期間中における市場成長の抑制要因になると考えられます。
調査範囲
本調査レポートでは、遠隔医療(テレヘルス&テレメディシン)市場を以下の項目に基づいて分類しています:構成要素(ハードウェア、ソフトウェア、サービス)、機能、用途、年齢層、エンドユーザー、および地域。ハードウェアには、テレヘルス用キット・カート・ステーションや、各種患者モニタリング機器(心臓、神経、呼吸器、血糖値、胎児・新生児、体重、多項目モニタリング、パルスオキシメーターなど)が含まれます。ソフトウェアについては、モダリティ(EHR中心型/非EHR中心型)、統合タイプ(統合型/スタンドアロン型)、種類(遠隔患者モニタリング、バーチャルケアプラットフォーム、ビデオ会議プラットフォーム、バーチャル・シッティング/ナーシング)、導入形態(オンプレミス型/クラウド型)といった観点から分類しています。機能面では、臨床ケア管理(遠隔診療やフォローアップを含む)、予防ケア管理、診断・治療、遠隔患者モニタリング、リハビリテーション・回復、管理業務、分析・レポーティング、患者エンゲージメント、その他(臨床試験、教育・研修など)を対象としています。用途としては、プライマリ・ケア、専門医療(遠隔放射線診断、遠隔心臓診療、遠隔神経診療、糖尿病、呼吸器疾患、高血圧、遠隔皮膚科、遠隔脳卒中診療、遠隔精神医療など)、テレICU、バーチャル・シッティング/ナーシングなどが含まれます。エンドユーザーには、医療提供者(病院、外来手術センター、長期療養・介護施設、在宅医療など)、医療費支払者(公的・民間保険者)、患者、製薬・バイオテクノロジー企業、医療機器企業などが含まれます。また、本レポートでは、テレヘルスおよび遠隔医療市場の成長に影響を与える主要な要因(促進要因、制約要因、課題、機会)について詳細に解説しています。さらに、主要な業界プレイヤーを徹底的に分析し、各社の事業概要や提供製品・サービスに加え、買収、提携、合併、製品・サービスの投入や機能強化、承認取得といった戦略に関する知見を提供します。加えて、本市場のエコシステムに参入する新興企業(スタートアップ)に関する競争分析も網羅しています。
本レポートを購入する理由
本レポートは、既存企業および新規参入企業や小規模企業が市場の動向を把握する一助となり、市場シェアの拡大につなげることができます。本レポートを購入した企業は、以下に挙げる戦略の1つ以上を活用することで、市場における自社の地位を強化することが可能です。
本レポートでは、以下の点に関する知見を提供します。
市場の成長要因(遠隔患者モニタリング(RPM)システムの拡大)、阻害要因(多額の投資コストやIT専門知識の不足)、機会(バーチャルケアにおけるウェアラブル端末、アプリ、センサーの利用拡大)、および課題(データセキュリティに関する懸念)といった、遠隔医療(テレヘルス&テレメディシン)市場の成長に影響を与える要素を分析しています。
- 製品開発・イノベーション:遠隔医療(テレヘルス&テレメディシン)市場における、今後の技術、研究開発活動、ならびに新製品・サービスの投入に関する詳細な知見。
- 市場展開:有望な市場に関する包括的な情報。本レポートでは、さまざまな地域における遠隔医療(テレヘルス&テレメディシン)市場を分析しています。
- 市場の多角化:遠隔医療(テレヘルス&テレメディシン)市場における新製品・サービス、未開拓の地域、最近の動向、および投資に関する網羅的な情報。
- 競合状況の評価:Koninklijke Philips N.V.(オランダ)、Medtronic(アイルランド)、GE Healthcare(米国)、Epic Systems Corporation(米国)、Oracle(米国)、Doximity, Inc.(米国)、Teladoc Health, Inc.(米国)といった主要企業について、市場シェア、成長戦略、提供サービスなどを詳細に評価しています。
Report Description
The telehealth and telemedicine market is projected to reach USD 198.9 billion by 2031 from USD 118.8 billion in 2026, at a CAGR of 10.9% from 2026 to 2031. The market is witnessing strong expansion, primarily driven by the growing geriatric and medically underserved populations, particularly in rural and remote areas, the rising prevalence of chronic diseases, and the increasing need for accessible healthcare amid persistent shortages of physicians and other healthcare professionals. In addition, advancements in telecommunications infrastructure, wider smartphone and internet penetration, cloud-based healthcare platforms, and the expanding adoption of remote patient monitoring (RPM) systems are further supporting market growth. The growing integration of AI-enabled medical devices, digital health platforms, and virtual consultations is also improving the scalability and efficiency of remote healthcare delivery. Healthcare providers, payers, and technology companies are increasingly adopting telehealth solutions to improve access to care, support continuous disease management, reduce unnecessary hospital visits, and enable more personalized patient engagement. However, regulatory variations across regions, growing concerns surrounding fraud and abuse within healthcare systems, data privacy and cybersecurity risks, interoperability challenges, and behavioral reluctance to adopt new technologies are expected to restrain market growth during the forecast period.
Key Takeaways
- MARKET SNAPSHOT:
Base Year Market Size (2025): USD 106.0 Billion
Current Market Size (2026): USD 118.8 Billion
Forecast Market Size (2031): USD 198.9 Billion
CAGR (2026–2031): 10.9% - SEGMENT LEADERSHIP:
Regional Leader: North America accounted for a share of 50.8% in 2025.
Component Leader: Software is expected to register the highest CAGR of 11.5% during the forecast period.
Function Leader: Remote patient monitoring is projected to grow at the fastest rate of 11.4% from 2026 to 2031.
Application Leader: Specialty care is expected to dominate the market.
Age Group Leader: Pediatrics will grow at the fastest rate of 12.7% during the forecast period.
End User Leader: Healthcare providers are expected to dominate the market with a market share of 46.7%. - MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
Koninklijke Philips N.V., Teladoc Health, Inc., and Oracle were identified as some of the star players in the global telehealth and telemedicine market, given their strong market share and product footprint.
Timedoc Health, Cerebral Inc., and Kindbody, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The patients segment is emerging as the fastest-growing end user in the telehealth and telemedicine market.
By end user, the patients segment is projected to register the fastest growth during the forecast period, supported by increasing consumer adoption of virtual consultations, remote patient monitoring, and digitally enabled healthcare services. Growing demand for convenient and accessible care, particularly among elderly individuals, patients with chronic conditions, and populations in rural or underserved areas, is encouraging more patients to directly engage with telehealth platforms. The increasing availability of smartphones, connected health devices, and user-friendly digital healthcare applications is further facilitating patient participation in remote care. In addition, the growing acceptance of virtual visits for primary care, follow-up consultations, behavioral health, and chronic disease management is expected to accelerate the expansion of the patients segment through 2031.

Telehealth and Telemedicine Market – Global Forecast to 2031 – by component
By component, the software segment accounted for the largest share of the telehealth and telemedicine market in 2025.
By component, the software segment is projected to account for the largest market share and register the fastest growth during the forecast period. The increasing adoption of telehealth platforms, virtual consultation applications, remote patient monitoring software, electronic health record integration, and digital care management solutions primarily drives this dominance. Healthcare providers are increasingly deploying software platforms to facilitate virtual consultations, streamline clinical workflows, enable real-time patient monitoring, and improve communication between patients and healthcare professionals. In addition, advancements in artificial intelligence, cloud computing, data analytics, and interoperability are enhancing the functionality and scalability of telehealth software solutions. The growing demand for integrated, user-friendly, and secure digital healthcare platforms is expected to further support the expansion of the software segment through 2031.

Telehealth and Telemedicine Market – Global Forecast to 2031 – by region
Asia Pacific is expected to register the highest growth during the forecast period.
By region, Asia Pacific (APAC) is projected to register the fastest growth during the forecast period, driven by the expanding healthcare needs of its large and rapidly aging population, rising prevalence of chronic diseases, and significant disparities in healthcare access across urban and rural areas. Increasing investments in digital healthcare infrastructure, improving internet and smartphone penetration, and the growing adoption of virtual consultations and remote patient monitoring are further supporting market expansion across the region. In addition, government initiatives promoting digital health, the development of telemedicine infrastructure, and increasing healthcare technology investments in countries such as China, India, Japan, South Korea, and Australia are creating favorable conditions for market growth. The region’s large patient population and growing demand for affordable and accessible healthcare services are expected to further accelerate the adoption of telehealth and telemedicine solutions through 2031.
The breakdown of primary participants is as mentioned below:
- By Company Type: Tier 1 (38%), Tier 2 (33%), and Tier 3 (29%)
- By Designation: Directors (35%), Managers (40%), and Others (25%)
- By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%), and the Middle East & Africa (2%)
Market Ecosystem
The telehealth and telemedicine market ecosystem consists of technology providers, network connectivity enablers, and healthcare end users. Key technology providers include Philips, Medtronic, GE HealthCare, Epic, Oracle, and Teladoc Health, which develop virtual care platforms, remote patient monitoring solutions, teleconsultation tools, electronic health record (EHR) integrations, and other digital health technologies that facilitate remote interactions between patients and healthcare providers. These companies increasingly focus on integrating telehealth capabilities with clinical workflows, data analytics, artificial intelligence, and connected medical devices to improve accessibility and continuity of care. Network connectivity enablers, including Juniper Networks, CenturyLink, NTT Communications, and Telefónica, provide the underlying telecommunications, cloud connectivity, network security, and data transmission infrastructure required to support reliable virtual healthcare delivery. High-speed, secure connectivity is especially important for real-time video consultations, remote monitoring, medical data transmission, and connected-device applications. Healthcare end users, such as Cleveland Clinic, Apollo Hospitals, and Norton Healthcare, represent the demand side of the ecosystem and drive the adoption of telehealth solutions across hospitals, specialty care, primary care, and chronic disease management. These organizations increasingly seek solutions that can expand patient reach, reduce unnecessary in-person visits, improve care coordination, and support patient-centered care delivery. Collaboration across the value chain from technology and connectivity providers to healthcare institutions is therefore essential for improving interoperability, strengthening data security, expanding access to virtual care, and enabling scalable and sustainable telehealth delivery.

Telehealth and Telemedicine Market – Global Forecast to 2031 – by ecosystem
Key Players
The prominent players operating in the telehealth and telemedicine market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Epic Systems Corporation (US), Oracle (US), Doximity, Inc. (US), Teladoc Health, Inc. (US), American Well (US), Siemens Healthineers AG (Germany), Cisco Systems Inc. (US), Included Health, Inc. (Doctor on Demand, Inc.) (US), AMC Health (US), TeleSpecialists (US), Walgreen Co. (US), and Caregility (US), among others. These companies have adopted strategies such as strategic partnerships, collaborations, product launches, platform enhancements, investments in AI, mergers and acquisitions, and geographic expansion to strengthen their market presence in the telehealth and telemedicine market.
Research Coverage
This research report categorizes the telehealth and telemedicine market by component {hardware [telehealth kits, carts, and stations; patient monitoring devices (cardiac monitoring devices, neurological monitoring devices, respiratory monitoring devices, blood glucose monitoring devices, fetal & neonatal monitoring devices, weight monitoring devices, multiparameter monitoring devices, pulse oximeter devices, and other monitoring devices)], software [modality (EHR-centric and non-EHR-centric), integration type (integrated software and standalone software), type (remote patient monitoring, virtual care platforms (real-time interaction, store & forward), video conferencing platforms, virtual sitting & nursing), deployment (on-premise model and cloud-based model), and services], function [clinical care management (including teleconsultation & follow-up), preventive care management, diagnostics & treatment, remote patient monitoring/patient monitoring, rehabilitation & recovery, administrative, analytics & reporting, patient engagement, other functions (clinical trials, education, training, and others)], application [primary care, specialty care (teleradiology, telecardiology, teleneurology, diabetes, respiratory disorders, hypertension, teledermatology, telestroke, telepsychiatry, and other specialty care applications), teleICU, virtual sitting & nursing, and other applications], age group (pediatrics, adults, and geriatrics), end user [healthcare providers (hospitals, ambulatory surgical centers, long-term care & assisted living facilities, home healthcare, and other healthcare providers), healthcare payers (public payers and private payers), patients, pharmaceutical & biotechnology companies, medtech companies, and other end users], and region. The report covers detailed information on major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the telehealth & telemedicine market. A thorough analysis of key industry players provides insights into their business overview, offerings, and key strategies such as acquisitions, collaborations, partnerships, mergers, product/service launches & enhancements, and approvals in the telehealth and telemedicine market. This report covers a competitive analysis of upcoming startups in the telehealth and telemedicine market ecosystem.
Reasons to Buy the Report
This report will help established firms and new entrants/smaller firms gauge the pulse of the market, which can help them gain greater market share. Firms that purchase the report can use one or more of the following strategies to strengthen their market position.
This report provides insights on:
Analysis of key drivers (expansion of remote patient monitoring (RPM) systems), restraints (high investment costs and lack of IT expertise), opportunities (growing use of wearables, apps, and sensors for virtual care), and challenges (data security concerns) influencing the growth of the telehealth and telemedicine market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the telehealth and telemedicine market.
- Market Development: Comprehensive information about lucrative markets; the report analyzes the telehealth and telemedicine market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the telehealth and telemedicine market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Epic Systems Corporation (US), Oracle (US), Doximity, Inc. (US), Teladoc Health, Inc. (US), etc., in the telehealth and telemedicine market.
Table of Contents
1 INTRODUCTION 40
1.1 STUDY OBJECTIVES 40
1.2 MARKET DEFINITION 40
1.2.1 TELEHEALTH 40
1.2.2 TELEMEDICINE 40
1.3 STUDY SCOPE 41
1.3.1 MARKETS COVERED & REGIONAL SCOPE 41
1.3.2 INCLUSIONS & EXCLUSIONS 42
1.3.3 YEARS CONSIDERED 44
1.4 CURRENCY CONSIDERED 44
1.5 STAKEHOLDERS 45
2 EXECUTIVE SUMMARY 46
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 46
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 47
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET 48
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 49
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 50
3 PREMIUM INSIGHTS 52
3.1 TELEHEALTH & TELEMEDICINE MARKET OVERVIEW 52
3.2 TELEHEALTH & TELEMEDICINE MARKET, BY END USER & REGION 53
3.3 TELEHEALTH & TELEMEDICINE MARKET: GEOGRAPHIC SNAPSHOT 54
4 MARKET OVERVIEW 55
4.1 INTRODUCTION 55
4.2 MARKET DYNAMICS 55
4.2.1 DRIVERS 56
4.2.1.1 Growing geriatric population and increasing need for advanced healthcare infrastructure 56
4.2.1.2 Rising prevalence of chronic diseases 56
4.2.1.3 Demonstrated time and cost savings 57
4.2.1.4 Advancements in telecommunication technologies 58
4.2.1.5 Shortage of skilled healthcare professionals 58
4.2.1.6 Increased government support and favorable regulatory policies 58
4.2.1.7 Expansion of remote patient monitoring systems 59
4.2.2 RESTRAINTS 60
4.2.2.1 High investment costs for B2B models and lack of IT expertise 60
4.2.2.2 State-to-state and inter-country regulatory variations 61
4.2.2.3 Behavioral reluctance to adopt new technologies 62
4.2.2.4 Rise in fraud and abuse in healthcare systems 62
4.2.2.5 Adherence to patient privacy, confidentiality, medical ethics 63
4.2.3 OPPORTUNITIES 63
4.2.3.1 Growing use of wearables, applications, and sensors for virtual care 63
4.2.3.2 Emergence of AI and ML 63
4.2.3.3 Increasing shift toward outpatient care models 64
4.2.3.4 High utility of telemedicine against infectious communicable diseases and epidemics 65
4.2.3.5 Expansion of hospital-at-home (HaH) initiatives 65
4.2.3.6 Demand for electronic medical record-based telehealth services 65
4.2.3.7 Rising incidence of mental illnesses and growing focus on emotional well-being 66
4.2.4 CHALLENGES 66
4.2.4.1 Data security and confidentiality concerns 66
4.2.4.2 Limited data accessibility 70
4.2.4.3 Inability to maintain patient hygiene and cleanliness standards 70
4.3 UNMET NEEDS AND WHITE SPACES 70
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 71
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 72
5 INDUSTRY TRENDS 73
5.1 PORTER’S FIVE FORCES ANALYSIS 73
5.1.1 THREAT OF NEW ENTRANTS 74
5.1.2 THREAT OF SUBSTITUTES 74
5.1.3 BARGAINING POWER OF BUYERS 74
5.1.4 BARGAINING POWER OF SUPPLIERS 75
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 75
5.2 MACROECONOMIC INDICATORS 75
5.2.1 INTRODUCTION 75
5.3 VALUE CHAIN ANALYSIS 76
5.4 ECOSYSTEM ANALYSIS 78
5.5 PRICING ANALYSIS 80
5.5.1 INDICATIVE PRICE FOR TELEHEALTH & TELEMEDICINE SOLUTIONS,
BY COMPONENT, 2026 81
5.5.2 INDICATIVE PRICING OF TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2026 82
5.6 KEY CONFERENCES & EVENTS, 2026–2027 82
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 83
5.8 INVESTMENT & FUNDING SCENARIO 84
5.9 CASE STUDY ANALYSIS 86
5.10 TARIFF AND REGULATORY ANALYSIS 88
5.10.1 TARIFF DATA ANALYSIS 88
5.10.1.1 Tariff data for HS code 9018 88
5.10.1.2 Tariff data for HS code 9021 89
5.10.1.3 Tariff data for HS code 9022 90
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL,
AND AI ADOPTION 91
6.1 INDUSTRY TRENDS 91
6.2 KEY EMERGING TECHNOLOGIES 95
6.2.1 VIDEO CONFERENCING AND REAL-TIME COMMUNICATION PLATFORMS 95
6.2.2 AI AND ML 95
6.2.3 VIRTUAL ASSISTANTS AND CHATBOTS 96
6.2.4 VOICE RECOGNITION AND NATURAL LANGUAGE PROCESSING (NLP) 96
6.2.5 EHR INTEGRATION 96
6.2.6 REMOTE PATIENT MONITORING SYSTEMS 96
6.3 COMPLEMENTARY TECHNOLOGIES 97
6.3.1 EDGE COMPUTING 97
6.3.2 CLOUD COMPUTING 97
6.3.3 MOBILE HEALTH (MHEALTH) APPLICATIONS 97
6.3.4 WEARABLE DEVICES, SENSORS, AND IOT 97
6.4 ADJACENT TECHNOLOGIES 98
6.4.1 DIGITAL THERAPEUTICS 98
6.4.2 BLOCKCHAIN TECHNOLOGY 98
6.4.3 AUGMENTED REALITY AND VIRTUAL REALITY 98
6.5 TECHNOLOGY / PRODUCT ROADMAP 99
6.6 PATENT ANALYSIS 100
6.6.1 PATENT PUBLICATION TRENDS FOR TELEHEALTH & TELEMEDICINE 100
6.6.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 100
6.7 FUTURE APPLICATIONS 103
6.7.1 REMOTE PATIENT MONITORING AND CHRONIC DISEASE MANAGEMENT 103
6.7.2 AI-ENABLED PERSONALIZED HEALTHCARE 104
6.7.3 VIRTUAL HOSPITALS AND HOSPITAL-AT-HOME CARE 104
6.8 IMPACT OF AI/GEN AI IN TELEHEALTH & TELEMEDICINE MARKET 104
6.8.1 KEY USE CASES 105
6.8.2 MAJOR CASE STUDIES 106
6.8.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 108
6.8.3.1 Healthcare IT and EHR systems 108
6.8.3.2 Pharmaceuticals & drug discovery 108
6.8.3.3 Mental health tech 109
6.8.3.4 Healthcare analytics and insights 109
6.8.4 USER READINESS & IMPACT ASSESSMENT 109
6.8.4.1 User readiness 109
6.8.4.1.1 User A: Hospitals 109
6.8.4.1.2 User B: Ambulatory surgery centers 109
6.8.4.2 Impact assessment 110
6.8.4.2.1 User A: Hospitals 110
6.8.4.2.2 USER B: Ambulatory surgery centers 110
7 REGULATORY LANDSCAPE 111
7.1 REGIONAL REGULATIONS AND COMPLIANCE 111
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
7.1.2 REGULATORY STANDARDS 113
7.1.3 REGULATORY FRAMEWORK 114
7.1.4 INDUSTRY STANDARDS 116
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 117
8.1 INTRODUCTION 117
8.2 DECISION-MAKING PROCESS 117
8.3 KEY STAKEHOLDERS & BUYING CRITERIA 118
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 118
8.3.2 KEY BUYING CRITERIA 119
8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 119
8.5 UNMET NEEDS & END-USER ANALYSIS 120
8.5.1 UNMET NEEDS 120
8.5.2 END USER EXPECTATIONS 121
8.6 MARKET PROFITABILITY 122
9 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP 123
9.1 INTRODUCTION 124
9.2 PEDIATRICS 124
9.2.1 EXPANDING ACCESS AND CARE THROUGH GROWTH OF PEDIATRIC TELEHEALTH ACROSS AGE GROUPS 124
9.3 ADULTS 125
9.3.1 SHIFT IN HEALTHCARE DELIVERY PREFERENCES DRIVES SEGMENT GROWTH 125
9.4 GERIATRICS 126
9.4.1 TRANSFORMING GERIATRIC CARE: RISE OF TELEHEALTH FOR ELDERLY PATIENTS 126
10 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION 128
10.1 INTRODUCTION 129
10.2 PRIMARY CARE 129
10.2.1 ANALYZING THE TRANSFORMATION OF PRIMARY CARE THROUGH TELEHEALTH INNOVATIONS 129
10.3 SPECIALTY CARE 130
10.3.1 SPECIALTY TELEHEALTH EXPANDS ACCESS TO EXPERT MEDICAL CARE 130
10.3.2 TELERADIOLOGY 132
10.3.2.1 Teleradiology transforms healthcare with faster diagnoses and greater accessibility 132
10.3.3 TELECARDIOLOGY 133
10.3.3.1 Revolutionizing cardiac care with telecardiology to expand access and efficiency 133
10.3.4 TELENEUROLOGY 134
10.3.4.1 Use of AI and cloud-based monitoring drives market 134
10.3.5 DIABETES 135
10.3.5.1 Driving growth in diabetes specialty care through telemedicine 135
10.3.6 RESPIRATORY DISORDERS (COPD, ASTHMA, AND OTHERS) 136
10.3.6.1 Driving growth in respiratory disorder management through telemedicine 136
10.3.7 HYPERTENSION 137
10.3.7.1 Transforming hypertension management with telehealth technologies 137
10.3.8 TELEDERMATOLOGY 138
10.3.8.1 Rising prevalence of skin diseases and growing use of HD cameras for skin diagnosis to drive market 138
10.3.9 TELESTROKE 139
10.3.9.1 Rising incidence of stroke and increasing geriatric population to drive market 139
10.3.10 TELEPSYCHIATRY (MENTAL HEALTH) 140
10.3.10.1 Shortage of mental health practitioners and favorable reimbursement scenario to drive market 140
10.3.11 OTHERS 141
10.3.11.1 Expanding telehealth solutions across diverse specialties: from oncology to ophthalmology 141
10.4 TELEICU 142
10.4.1 INCREASING NUMBER OF PATIENTS IN EMERGENCY DEPARTMENTS AND STAFF SHORTAGE IN RURAL AREAS TO DRIVE MARKET 142
10.5 VIRTUAL SITTING & NURSING 143
10.5.1 DRIVING GROWTH IN VIRTUAL SITTING AND NURSING THROUGH TELEHEALTH & TELEMEDICINE 143
10.6 OTHER APPLICATIONS 144
10.6.1 EXPANDING TELEHEALTH GROWTH ACROSS DIVERSE APPLICATIONS:
CLINICAL TRIALS, URGENT CARE, AND WELLNESS 144
11 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT 145
11.1 INTRODUCTION 146
11.1.1 HARDWARE 146
11.1.1.1 Transforming telehealth and telemedicine with advanced hardware solutions 146
11.1.2 TELEHEALTH KITS, CARTS, AND STATIONS 147
11.1.2.1 Empowering remote care with telehealth kits, carts, and stations 147
11.1.3 PATIENT MONITORING DEVICES 148
11.1.3.1 Empowering telehealth with advanced patient monitoring solutions 148
11.1.3.2 Cardiac monitoring devices 149
11.1.3.2.1 Empowering remote cardiac care through advanced monitoring solutions 149
11.1.3.3 Neurological monitoring devices 149
11.1.3.3.1 Transforming neurocare with advanced telemedicine solutions 149
11.1.3.4 Respiratory monitoring devices 150
11.1.3.4.1 Transforming respiratory care with remote monitoring solutions 150
11.1.3.5 Blood glucose monitoring devices 151
11.1.3.5.1 Revolutionizing diabetes management through remote monitoring 151
11.1.3.6 Fetal & neonatal monitoring devices 151
11.1.3.6.1 Enhancing maternal and infant care with remote monitoring solutions 151
11.1.3.7 Weight monitoring devices 152
11.1.3.7.1 Supporting weight management through remote monitoring technologies 152
11.1.3.8 Multiparameter monitoring devices 153
11.1.3.8.1 Elevating remote care with multiparameter monitoring devices 153
11.1.3.9 Pulse oximeter devices 153
11.1.3.9.1 Improved patient outcomes and reduced costs drive market 153
11.1.3.10 Other monitoring devices 154
11.1.3.10.1 Expanding telehealth capabilities with diverse monitoring devices 154
11.2 SOFTWARE 155
11.2.1 DRIVING TELEHEALTH INNOVATION THROUGH ADVANCED SOFTWARE SOLUTIONS 155
11.2.2 BY MODALITY 155
11.2.2.1 Leveraging EHR-centric and non-EHR-centric software modalities in telehealth 155
11.2.2.2 EHR Centric 156
11.2.2.2.1 Enhancing telehealth with EHR-centric software solutions 156
11.2.2.3 Non-HER Centric 157
11.2.2.3.1 Leveraging non-EHR centric software in telehealth and telemedicine 157
11.2.3 BY INTEGRATION TYPE 157
11.2.3.1 Maximizing telemedicine efficiency with integrated and standalone software solutions 157
11.2.3.2 Integrated Software 158
11.2.3.2.1 Advancements in technology to boost segment 158
11.2.3.3 Standalone software 159
11.2.3.3.1 Additional features that offer flexibility drive market 159
11.2.4 TYPE 159
11.2.4.1 Transforming telehealth with remote patient monitoring and virtual care platforms 159
11.2.4.2 Remote patient monitoring 160
11.2.4.2.1 Convenience of tracking patient vitals from different places to drive segment 160
11.2.4.3 Virtual care platform 161
11.2.4.3.1 Driving digital transformation in telemedicine through virtual care platforms 161
11.2.4.3.2 Real-time interaction 162
11.2.4.3.2.1 Synchronous nature and potential for better healthcare access to drive segment 162
11.2.4.3.3 Store and forward 163
11.2.4.3.3.1 Easy monitoring of vital signs for long-term chronic care without physical presence to drive segment 163
11.2.4.4 Video conferencing platforms 163
11.2.4.4.1 Revolutionizing Remote Care Delivery with Video Conferencing Platforms 163
11.2.4.5 Virtual sitting & nursing 164
11.2.4.5.1 Proactive patient monitoring to improve outcomes and reduce costs 164
11.2.5 BY DEPLOYMENT 165
11.2.5.1 Transforming telehealth with remote patient monitoring and virtual care platforms 165
11.2.5.2 On-premise model 166
11.2.5.2.1 Enhanced control of software and easy reuse of existing infrastructure to drive market 166
11.2.5.3 Cloud-based model 167
11.2.5.3.1 Cloud-based model segment to dominate market during forecast period 167
11.2.6 SERVICES 168
11.2.6.1 Key role in enhancing telehealth and telemedicine to boost segment 168
12 TELEHEALTH & TELEMEDICINE MARKET, BY END USER 169
12.1 INTRODUCTION 170
12.2 HEALTHCARE PROVIDERS 170
12.2.1 HOSPITALS 172
12.2.1.1 Growing incidence of chronic diseases and rising demand for high-quality care to drive segment 172
12.2.2 AMBULATORY SURGICAL CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS 173
12.2.2.1 Increasing preference for same-day surgeries and demand for cost-effective care to drive adoption of telehealth and telemedicine 173
12.2.3 LONG-TERM CARE AND ASSISTED LIVING FACILITIES 174
12.2.3.1 Increasing geriatric population and rising need for prolonged treatment for chronic diseases to drive segment 174
12.2.4 HOME HEALTHCARE 175
12.2.4.1 Rising aging population and growing focus on patient-centered care to propel home healthcare segment 175
12.2.5 OTHER HEALTHCARE PROVIDERS 175
12.2.5.1 Advancements in technology and increasing need for comprehensive care to drive adoption across specialized centers 175
12.3 HEALTHCARE PAYERS 176
12.3.1 PUBLIC PAYERS 177
12.3.1.1 Increasing investments by public payers to drive segment 177
12.3.2 PRIVATE PAYERS 178
12.3.2.1 Expansion of telehealth services to mental health and substance usage to drive segment 178
12.4 PATIENTS 179
12.4.1 RISING PREVALENCE OF CHRONIC DISEASES AND EMERGENCE OF ADVANCED WEARABLE MONITORS TO DRIVE MARKET 179
12.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 180
12.5.1 ADVANCEMENTS IN TELEMEDICINE PROVIDE PHARMACEUTICAL AND BIOTECH COMPANIES WITH NEW AVENUES FOR DRUG DEVELOPMENT AND MONITORING 180
12.6 MEDTECH COMPANIES 181
12.6.1 ADVANCING REMOTE CARE THROUGH INNOVATIVE TELEHEALTH SOLUTIONS DRIVES GROWTH FOR MEDTECH COMPANIES 181
12.7 OTHER END USERS 182
13 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION 183
13.1 INTRODUCTION 184
13.2 CLINICAL CARE MANAGEMENT 185
13.2.1 OPTIMIZING TELEMEDICINE THROUGH EFFECTIVE CLINICAL CARE MANAGEMENT 185
13.3 PREVENTIVE CARE MANAGEMENT 186
13.3.1 OPTIMIZING TELEMEDICINE THROUGH EFFECTIVE CLINICAL CARE MANAGEMENT 186
13.4 DIAGNOSTICS & TREATMENT 187
13.4.1 OPTIMIZING TELEMEDICINE THROUGH EFFECTIVE CLINICAL CARE MANAGEMENT 187
13.5 REMOTE PATIENT MONITORING/PATIENT MONITORING 188
13.5.1 SEAMLESS PATIENT CARE THROUGH REMOTE MONITORING TECHNOLOGIES 188
13.6 REHABILITATION & RECOVERY 189
13.6.1 REDEFINING REMOTE RECOVERY WITH TELEREHABILITATION IN THE DIGITAL AGE 189
13.7 ADMINISTRATIVE 190
13.7.1 OPTIMIZING ADMINISTRATIVE SEGMENTS IN TELEHEALTH FOR ENHANCED WORKFLOW EFFICIENCY 190
13.8 ANALYTICS & REPORTING 191
13.8.1 SEAMLESS PATIENT CARE THROUGH REMOTE MONITORING TECHNOLOGIES 191
13.9 PATIENT ENGAGEMENT 192
13.9.1 EMPOWERING PATIENTS THROUGH ENGAGEMENT IN TELEHEALTH TRANSFORMATION 192
13.10 OTHER FUNCTIONS 193
13.10.1 EDUCATION & TRAINING PRACTICES TO LEAD TO TELEHEALTH GROWTH 193
14 TELEHEALTH & TELEMEDICINE MARKET, BY REGION 194
14.1 INTRODUCTION 195
14.2 NORTH AMERICA 195
14.2.1 US 203
14.2.1.1 Legislative extensions as a driving force in expanding telehealth and telemedicine access to drive market. 203
14.2.2 CANADA 210
14.2.2.1 Government investments and digital integration to fuel the market 210
14.3 EUROPE 216
14.3.1 GERMANY 223
14.3.1.1 Key legislative reforms driving the digital transformation of healthcare in Germany 223
14.3.2 UK 229
14.3.2.1 Accelerating healthcare access and efficiency through digital transformation is driving the market 229
14.3.3 FRANCE 236
14.3.3.1 Strategic investments and policy reforms are driving the market 236
14.3.4 ITALY 242
14.3.4.1 Strategic government investments fuel growth in Italy’s telehealth market. 242
14.3.5 SPAIN 249
14.3.5.1 Surging investment and increasing adoption of wearable technology is driving the market 249
14.3.6 REST OF EUROPE 256
14.4 ASIA PACIFIC 262
14.4.1 CHINA 270
14.4.1.1 Advancing digital health infrastructure to drive market in China 270
14.4.2 JAPAN 276
14.4.2.1 Government reforms and technological advancements driving growth in Japan’s telemedicine market. 276
14.4.3 INDIA 283
14.4.3.1 Government initiatives for digitalization is driving the market in India 283
14.4.4 AUSTRALIA 289
14.4.4.1 Government investment in rural aged care is driving the market in Australia 289
14.4.5 REST OF ASIA PACIFIC 296
14.5 LATIN AMERICA 302
14.5.1 EXPANDING ACCESS THROUGH DIGITAL INNOVATION 302
14.5.2 BRAZIL 309
14.5.2.1 Bridging gaps with telemedicine 309
14.5.3 MEXICO 316
14.5.3.1 Mexico’s digital healthcare expansion: telehealth & telemedicine advancements 316
14.5.4 REST OF LATIN AMERICA 323
14.6 MIDDLE EAST & AFRICA 329
14.6.1 GOVERNMENT INITIATIVES TO SUPPORT MARKET GROWTH FOR TELEHEALTH & TELEMEDICINE SOLUTION 329
14.6.2 GCC COUNTRIES 336
14.6.2.1 Shortage of healthcare workforce to support market growth 336
14.6.3 REST OF MIDDLE EAST & AFRICA 342
14.6.3.1 Improvement in healthcare infrastructure to support telemedicine and telehealth platforms 342
15 COMPETITIVE LANDSCAPE 350
15.1 OVERVIEW 350
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 350
15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN TELEHEALTH AND TELEMEDICINE MARKET 351
15.3 REVENUE ANALYSIS, 2021–2025 355
15.4 MARKET SHARE ANALYSIS, 2025 356
15.5 COMPANY VALUATION AND FINANCIAL METRICS 359
15.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 360
15.6.1 STARS 360
15.6.2 EMERGING LEADERS 360
15.6.3 PERVASIVE PLAYERS 360
15.6.4 PARTICIPANTS 360
15.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 362
15.6.5.1 Company footprint 362
15.6.5.2 Region footprint 363
15.6.5.3 Function footprint 364
15.6.5.4 Application footprint 365
15.6.5.5 Component footprint 366
15.6.5.6 End user footprint 367
15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 368
15.7.1 PROGRESSIVE COMPANIES 368
15.7.2 RESPONSIVE COMPANIES 368
15.7.3 DYNAMIC COMPANIES 368
15.7.4 STARTING BLOCKS 368
15.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 370
15.7.5.1 Detailed list of key startups/SMEs 370
15.7.5.2 Competitive benchmarking of key startups/SMEs 370
15.8 BRAND/SOFTWARE COMPARATIVE ANALYSIS 371
15.9 COMPETITIVE SCENARIO 372
15.9.1 PRODUCT LAUNCHES & APPROVALS 372
15.9.2 DEALS 373
15.9.3 EXPANSIONS 374
15.9.4 OTHER DEVELOPMENTS 375
16 COMPANY PROFILES 376
16.1 KEY PLAYERS 376
16.1.1 MEDTRONIC 376
16.1.1.1 Business overview 376
16.1.1.2 Products/Services/Solutions offered 378
16.1.1.3 Recent developments 380
16.1.1.3.1 Product launches and enhancements 380
16.1.1.3.2 Deals 380
16.1.1.4 MnM view 381
16.1.1.4.1 Right to win 381
16.1.1.4.2 Strategic choices 381
16.1.1.4.3 Weaknesses & competitive threats 381
16.1.2 TELADOC HEALTH, INC. 382
16.1.2.1 Business overview 382
16.1.2.2 Products/Services/Solutions offered 384
16.1.2.3 Recent developments 385
16.1.2.3.1 Product launches and enhancements 385
16.1.2.3.2 Deals 386
16.1.2.4 MnM view 387
16.1.2.4.1 Right to win 387
16.1.2.4.2 Strategic choices 387
16.1.2.4.3 Weaknesses & competitive threats 387
16.1.3 CISCO SYSTEMS, INC. 388
16.1.3.1 Business overview 388
16.1.3.2 Products/Services/Solutions offered 390
16.1.4 DEALS 391
16.1.4.1 MnM view 391
16.1.4.1.1 Right to win 391
16.1.4.1.2 Strategic choices 391
16.1.4.1.3 Weaknesses & competitive threats 391
16.1.5 KONINKLIJKE PHILIPS N.V. 392
16.1.5.1 Business overview 392
16.1.5.2 Products/Services/Solutions offered 394
16.1.5.3 Recent developments 396
16.1.5.3.1 Product launches & approvals 396
16.1.5.3.2 Deals 397
16.1.5.4 MnM view 398
16.1.5.4.1 Right to win 398
16.1.5.4.2 Strategic choices 398
16.1.5.4.3 Weaknesses & competitive threats 398
16.1.6 ZOOM COMMUNICATIONS, INC. 399
16.1.6.1 Business overview 399
16.1.6.2 Products/Services/Solutions offered 400
16.1.6.3 Recent developments 400
16.1.6.3.1 Deals 400
16.1.6.4 MnM view 401
16.1.6.4.1 Right to win 401
16.1.6.4.2 Strategic choices 401
16.1.6.4.3 Weaknesses & competitive threats 402
16.1.7 GE HEALTHCARE 403
16.1.7.1 Business overview 403
16.1.7.2 Products/Services/Solutions offered 405
16.1.7.3 Recent developments 406
16.1.7.3.1 Product launches 406
16.1.7.3.2 Deals 406
16.1.7.3.3 Other developments 407
16.1.8 EPIC SYSTEMS CORPORATION 408
16.1.8.1 Business overview 408
16.1.8.2 Products/Services/Solutions offered 408
16.1.8.3 Recent developments 410
16.1.8.3.1 Product launches and enhancements 410
16.1.8.3.2 Deals 411
16.1.9 ORACLE 412
16.1.9.1 Business overview 412
16.1.9.2 Products/Services/Solutions offered 414
16.1.9.3 Recent developments 415
16.1.9.3.1 Product launches 415
16.1.9.3.2 Deals 416
16.1.10 DOXIMITY, INC. 418
16.1.10.1 Business overview 418
16.1.10.2 Products/Services/Solutions offered 419
16.1.10.3 Recent developments 420
16.1.10.3.1 Product enhancements 420
16.1.10.3.2 Deals 420
16.1.10.3.3 Other developments 421
16.1.11 AMERICAN WELL 422
16.1.11.1 Business overview 422
16.1.11.2 Products/Services/Solutions offered 423
16.1.11.3 Recent developments 424
16.1.11.3.1 Product launches 424
16.1.11.3.2 Deals 424
16.1.11.3.3 Other developments 425
16.1.12 SIEMENS HEALTHINEERS AG 426
16.1.12.1 Business overview 426
16.1.12.2 Products/Services/Solutions offered 428
16.1.12.3 Recent developments 429
16.1.12.3.1 Product launches 429
16.1.12.3.2 Deals 429
16.1.13 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.) 431
16.1.13.1 Business overview 431
16.1.13.2 Products/Services/Solutions offered 432
16.1.13.3 Recent developments 432
16.1.13.3.1 DEALS 432
16.1.13.3.2 Other developments 434
16.1.14 AMC HEALTH 435
16.1.14.1 Business overview 435
16.1.14.2 Products/Services/Solutions offered 435
16.1.14.3 Recent developments 436
16.1.14.3.1 Deals 436
16.1.15 TELESPECIALISTS 437
16.1.15.1 Business overview 437
16.1.15.2 Products/Services/Solutions offered 437
16.1.15.3 Recent developments 438
16.1.15.3.1 Product launches 438
16.1.15.3.2 Other developments 438
16.1.16 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.) 439
16.1.16.1 Business overview 439
16.1.16.2 Products/Services/Solutions offered 440
16.1.16.3 Recent developments 440
16.1.16.3.1 Product launches 440
16.1.16.3.2 Deals 440
16.1.16.3.3 Expansions 441
16.1.16.3.4 Other developments 441
16.1.17 CAREGILITY 442
16.1.17.1 Business overview 442
16.1.17.2 Products/Services offered 442
16.1.17.3 Recent developments 443
16.1.17.3.1 Deals 443
16.1.18 CVS HEALTH 444
16.1.18.1 Business overview 444
16.1.18.2 Products/Services/Solutions offered 445
16.1.18.3 Recent developments 445
16.1.18.3.1 Product launches 445
16.1.18.3.2 Deals 446
16.1.19 EVERNORTH HEALTH, INC. 447
16.1.19.1 Products/Services/Solutions offered 449
16.1.19.2 Recent developments 449
16.1.19.2.1 Deals 449
16.1.20 ELATION 450
16.1.20.1 Business overview 450
16.1.20.2 Products/Services/Solutions offered 450
16.1.20.3 Recent developments 450
16.1.20.3.1 Deals 450
16.1.21 IRON BOW TECHNOLOGIES 451
16.1.21.1 Business overview 451
16.1.21.2 Products/Services/Solutions offered 452
16.2 OTHER PLAYERS 453
16.2.1 TIMEDOC, INC. 453
16.2.2 CEREBRAL INC. 454
16.2.3 KINDBODY 455
16.2.4 TRANSCARENT 456
16.2.5 CARESIMPLE INC. 457
17 RESEARCH METHODOLOGY 458
17.1 RESEARCH DATA 458
17.1.1 SECONDARY DATA 459
17.1.1.1 Key data from secondary sources 460
17.1.2 PRIMARY DATA 460
17.1.2.1 Key data from primary sources 461
17.1.2.2 Insights from primary experts 462
17.2 MARKET SIZE ESTIMATION 463
17.3 DATA TRIANGULATION 467
17.4 MARKET SHARE ESTIMATION 468
17.5 RESEARCH ASSUMPTIONS 468
17.6 LIMITATIONS 468
17.6.1 METHODOLOGY-RELATED LIMITATIONS 468
17.6.2 SCOPE-RELATED LIMITATIONS 468
17.7 RISK ASSESSMENT 469
18 APPENDIX 470
18.1 DISCUSSION GUIDE 470
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 477
18.3 CUSTOMIZATION OPTIONS 479
18.4 RELATED REPORTS 479
18.5 AUTHOR DETAILS 480
LIST OF TABLES
TABLE 1 CHRONIC DISEASES AND RELATED COST BURDEN IN US 57
TABLE 2 RECENT DEVELOPMENTS FOR REMOTE PATIENT MONITORING SYSTEMS,
JANUARY 2023–JANUARY 2026 59
TABLE 3 US: STATE-WISE REGULATORY REQUIREMENTS FOR TELEHEALTH 61
TABLE 4 TOP 30 HEALTHCARE DATA BREACHES IN US, 2011−2024 68
TABLE 5 TELEHEALTH & TELEMEDICINE MARKET: PORTER’S FIVE FORCES 74
TABLE 6 TELEHEALTH & TELEMEDICINE MARKET: ROLE IN ECOSYSTEM 79
TABLE 7 COST RANGE INVOLVED IN TELEMEDICINE DEVICES (USD) 80
TABLE 8 INDICATIVE PRICE FOR TELEHEALTH & TELEMEDICINE SOLUTIONS,
BY COMPONENT, 2026 81
TABLE 9 AVERAGE SELLING PRICE OF TELADOC CONSULTATIONS 81
TABLE 10 INDICATIVE PRICING OF TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2026 82
TABLE 11 TELEHEALTH & TELEMEDICINE MARKET: KEY CONFERENCES & EVENTS, 2026–2027 83
TABLE 12 CASE 1: TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH TEBRA’S INTEGRATED SOLUTIONS 86
TABLE 13 CASE 2: USE OF TELEHEALTH TO REDUCE PREVENTABLE EMERGENCY ROOM TRANSFERS FROM SKILLED NURSING FACILITIES 86
TABLE 14 CASE 3: CONE HEALTH TO REVOLUTIONIZE TELEICU AND TELEHEALTH FOR SEAMLESS TRANSITION TO CAREGILITY’S UNIVERSAL HEALTH ENGAGEMENT SOLUTIONS 87
TABLE 15 AVERAGE TARIFF FOR HS CODE 9018, 2025 88
TABLE 16 AVERAGE TARIFF FOR HS CODE 9021, 2025 89
TABLE 17 AVERAGE TARIFF FOR HS CODE 9022, 2025 90
TABLE 18 INDUSTRY TRENDS IN TELEHEALTH & TELEMEDICINE MARKET 91
TABLE 19 OVERVIEW OF TELEHEALTH USE CASES 94
TABLE 20 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR TELEHEALTH & TELEHEALTH 100
TABLE 21 TELEHEALTH AND TELEMEDICINE MARKET: LIST OF PATENTS/PATENT APPLICATIONS 102
TABLE 22 AI TO REDEFINE TREATMENT EFFECTIVENESS AND SAFETY 106
TABLE 23 AI-DRIVEN CHATBOTS AND TELEHEALTH TO ENHANCE MENTAL HEALTH AND
CHRONIC DISEASE MANAGEMENT 107
TABLE 24 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 111
TABLE 25 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112
TABLE 26 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 113
TABLE 27 TELEHEALTH & TELEMEDICINE MARKET: REGULATORY STANDARDS 113
TABLE 28 REGULATORY REQUIREMENTS IN NORTH AMERICA 114
TABLE 29 REGULATORY REQUIREMENTS IN EUROPE 114
TABLE 30 REGULATORY REQUIREMENTS IN ASIA PACIFIC 115
TABLE 31 REGULATORY REQUIREMENTS IN LATIN AMERICA 116
TABLE 32 REGULATORY REQUIREMENTS IN MIDDLE EAST & AFRICA 116
TABLE 33 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE 118
TABLE 34 KEY BUYING CRITERIA FOR TOP THREE COMPONENTS 119
TABLE 35 UNMET NEEDS IN TELEHEALTH & TELEMEDICINE MARKET 120
TABLE 36 END-USER EXPECTATIONS IN TELEHEALTH & TELEMEDICINE MARKET 121
TABLE 37 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2024–2031 (USD MILLION) 124
TABLE 38 TELEHEALTH & TELEMEDICINE MARKET FOR PEDIATRICS,
BY REGION, 2024–2031 (USD MILLION) 125
TABLE 39 TELEHEALTH & TELEMEDICINE MARKET FOR ADULTS,
BY REGION, 2024–2031 (USD MILLION) 126
TABLE 40 TELEHEALTH & TELEMEDICINE MARKET FOR GERIATRICS,
BY REGION, 2024–2031 (USD MILLION) 127
TABLE 41 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 129
TABLE 42 TELEHEALTH & TELEMEDICINE MARKET FOR PRIMARY CARE,
BY REGION, 2024–2031 (USD MILLION) 130
TABLE 43 TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 131
TABLE 44 TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY REGION, 2024–2031 (USD MILLION) 132
TABLE 45 TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY,
BY REGION, 2024–2031 (USD MILLION) 133
TABLE 46 TELEHEALTH & TELEMEDICINE MARKET FOR TELECARDIOLOGY,
BY REGION, 2024–2031 (USD MILLION) 134
TABLE 47 TELEHEALTH & TELEMEDICINE MARKET FOR TELENEUROLOGY,
BY REGION, 2024–2031 (USD MILLION) 135
TABLE 48 TELEHEALTH & TELEMEDICINE MARKET FOR DIABETES,
BY REGION 2024–2031 (USD MILLION) 136
TABLE 49 TELEHEALTH & TELEMEDICINE MARKET FOR RESPIRATORY DISORDERS,
BY REGION, 2024–2031 (USD MILLION) 137
TABLE 50 TELEHEALTH & TELEMEDICINE MARKET FOR HYPERTENSION,
BY REGION, 2024–2031 (USD MILLION) 137
TABLE 51 TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY,
BY REGION, 2024–2031 (USD MILLION) 138
TABLE 52 TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE,
BY REGION, 2024–2031 (USD MILLION) 139
TABLE 53 TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY (MENTAL HEALTH),
BY REGION, 2024–2031 (USD MILLION) 140
TABLE 54 TELEHEALTH & TELEMEDICINE MARKET FOR OTHERS,
BY REGION, 2024–2031 (USD MILLION) 141
TABLE 55 TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU,
BY REGION, 2024–2031 (USD MILLION) 142
TABLE 56 TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL SITTING & NURSING,
BY REGION, 2024–2031 (USD MILLION) 143
TABLE 57 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS,
BY REGION, 2024–2031 (USD MILLION) 144
TABLE 58 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 146
TABLE 59 TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY REGION, 2024–2031 (USD MILLION) 147
TABLE 60 TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 147
TABLE 61 TELEHEALTH & TELEMEDICINE MARKET FOR TELEHEALTH KITS, CARTS,
AND STATIONS, BY REGION, 2024–2031 (USD MILLION) 148
TABLE 62 TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES,
BY REGION, 2024–2031 (USD MILLION) 148
TABLE 63 TELEHEALTH & TELEMEDICINE MARKET FOR CARDIAC MONITORING DEVICES,
BY REGION, 2024–2031 (USD MILLION) 149
TABLE 64 TELEHEALTH & TELEMEDICINE MARKET FOR NEUROLOGICAL MONITORING DEVICES,
BY REGION, 2024–2031 (USD MILLION) 150
TABLE 65 TELEHEALTH & TELEMEDICINE MARKET FOR RESPIRATORY MONITORING DEVICES,
BY REGION, 2024–2031 (USD MILLION) 150
TABLE 66 TELEHEALTH & TELEMEDICINE MARKET FOR BLOOD GLUCOSE MONITORING DEVICES,
BY REGION, 2024–2031 (USD MILLION) 151
TABLE 67 TELEHEALTH & TELEMEDICINE MARKET FOR FETAL & NEONATAL MONITORING DEVICES,
BY REGION, 2024–2031 (USD MILLION) 152
TABLE 68 TELEHEALTH & TELEMEDICINE MARKET FOR WEIGHT MONITORING DEVICES,
BY REGION, 2024–2031 (USD MILLION) 152
TABLE 69 TELEHEALTH & TELEMEDICINE MARKET FOR MULTIPARAMETER MONITORING DEVICES,
BY REGION, 2024–2031 (USD MILLION) 153
TABLE 70 TELEHEALTH & TELEMEDICINE MARKET FOR PULSE OXIMETER DEVICES,
BY REGION, 2024–2031 (USD MILLION) 154
TABLE 71 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER MONITORING DEVICES,
BY REGION, 2024–2031 (USD MILLION) 154
TABLE 72 TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY REGION, 2024–2031 (USD MILLION) 155
TABLE 73 TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 156
TABLE 74 TELEHEALTH & TELEMEDICINE MARKET FOR EHR CENTRIC MODALITIES,
BY REGION, 2024–2031 (USD MILLION) 156
TABLE 75 TELEHEALTH & TELEMEDICINE MARKET FOR NON-EHR CENTRIC MODALITIES,
BY REGION, 2024–2031 (USD MILLION) 157
TABLE 76 TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 158
TABLE 77 TELEHEALTH & TELEMEDICINE MARKET FOR INTEGRATED SOFTWARE,
BY REGION, 2024–2031 (USD MILLION) 158
TABLE 78 TELEHEALTH & TELEMEDICINE MARKET FOR STANDALONE SOFTWARE,
BY REGION, 2024–2031 (USD MILLION) 159
TABLE 79 TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 160
TABLE 80 TELEHEALTH & TELEMEDICINE MARKET FOR REMOTE PATIENT MONITORING,
BY REGION, 2024–2031 (USD MILLION) 161
TABLE 81 TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL CARE PLATFORMS,
BY REGION, 2024–2031 (USD MILLION) 162
TABLE 82 TELEHEALTH & TELEMEDICINE MARKET FOR VIDEO CONFERENCING PLATFORMS,
BY REGION, 2024–2031 (USD MILLION) 164
TABLE 83 TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL SITTING & NURSING,
BY REGION, 2024–2031 (USD MILLION) 165
TABLE 84 TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 166
TABLE 85 TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE MODEL,
BY REGION, 2024–2031 (USD MILLION) 166
TABLE 86 TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED MODEL,
BY REGION, 2024–2031 (USD MILLION) 167
TABLE 87 TELEHEALTH & TELEMEDICINE MARKET FOR SERVICES,
BY REGION, 2024–2031 (USD MILLION) 168
TABLE 88 TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2024–2031 (USD MILLION) 170
TABLE 89 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 171
TABLE 90 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY REGION, 2024–2031 (USD MILLION) 171
TABLE 91 TELEHEALTH & TELEMEDICINE MARKET FOR HOSPITALS,
BY REGION, 2024–2031 (USD MILLION) 172
TABLE 92 TELEHEALTH & TELEMEDICINE MARKET FOR AMBULATORY SURGICAL CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS,
BY REGION, 2024–2031 (USD MILLION) 173
TABLE 93 TELEHEALTH & TELEMEDICINE MARKET FOR LONG-TERM CARE AND ASSISTED LIVING FACILITIES, BY REGION, 2024–2031 (USD MILLION) 174
TABLE 94 TELEHEALTH & TELEMEDICINE MARKET FOR HOME HEALTHCARE,
BY REGION, 2024–2031 (USD MILLION) 175
TABLE 95 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER HEALTHCARE PROVIDERS,
BY REGION, 2024–2031 (USD MILLION) 176
TABLE 96 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 177
TABLE 97 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY REGION, 2024–2031 (USD MILLION) 177
TABLE 98 TELEHEALTH & TELEMEDICINE MARKET FOR PUBLIC PAYERS,
BY REGION, 2024–2031 (USD MILLION) 178
TABLE 99 TELEHEALTH & TELEMEDICINE MARKET FOR PRIVATE PAYERS,
BY REGION, 2024–2031 (USD MILLION) 179
TABLE 100 TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS,
BY REGION, 2024–2031 (USD MILLION) 180
TABLE 101 TELEHEALTH & TELEMEDICINE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 181
TABLE 102 TELEHEALTH & TELEMEDICINE MARKET FOR MEDTECH COMPANIES,
BY REGION, 2024–2031 (USD MILLION) 182
TABLE 103 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS,
BY REGION, 2024–2031 (USD MILLION) 182
TABLE 104 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 184
TABLE 105 TELEHEALTH & TELEMEDICINE MARKET FOR CLINICAL CARE MANAGEMENT,
BY REGION, 2024–2031 (USD MILLION) 185
TABLE 106 TELEHEALTH & TELEMEDICINE MARKET FOR PREVENTIVE CARE MANAGEMENT,
BY REGION, 2024–2031 (USD MILLION) 186
TABLE 107 TELEHEALTH & TELEMEDICINE MARKET FOR DIAGNOSTICS & TREATMENT,
BY REGION, 2024–2031 (USD MILLION) 187
TABLE 108 TELEHEALTH & TELEMEDICINE MARKET FOR REMOTE PATIENT MONITORING/PATIENT MONITORING, BY REGION, 2024–2031 (USD MILLION) 188
TABLE 109 TELEHEALTH & TELEMEDICINE MARKET FOR REHABILITATION & RECOVERY,
BY REGION, 2024–2031 (USD MILLION) 189
TABLE 110 TELEHEALTH & TELEMEDICINE MARKET FOR ADMINISTRATIVE,
BY REGION, 2024–2031 (USD MILLION) 190
TABLE 111 TELEHEALTH & TELEMEDICINE MARKET FOR ANALYTICS & REPORTING,
BY REGION, 2024–2031 (USD MILLION) 191
TABLE 112 TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT ENGAGEMENT,
BY REGION, 2024–2031 (USD MILLION) 192
TABLE 113 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER FUNCTIONS,
BY REGION, 2024–2031 (USD MILLION) 193
TABLE 114 TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2024–2031 (USD MILLION) 195
TABLE 115 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 196
TABLE 116 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET,
BY COMPONENT, 2024–2031 (USD MILLION) 197
TABLE 117 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 197
TABLE 118 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 198
TABLE 119 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 198
TABLE 120 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 199
TABLE 121 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET,
BY FUNCTION, 2024–2031 (USD MILLION) 199
TABLE 122 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 200
TABLE 123 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 124 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET,
BY AGE GROUP, 2024–2031 (USD MILLION) 201
TABLE 125 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET,
BY END USER, 2024–2031 (USD MILLION) 202
TABLE 126 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 202
TABLE 127 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 203
TABLE 128 US: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 204
TABLE 129 US: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 204
TABLE 130 US: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 205
TABLE 131 US: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 205
TABLE 132 US: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 206
TABLE 133 US: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 206
TABLE 134 US: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 206
TABLE 135 US: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 207
TABLE 136 US: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 207
TABLE 137 US: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 208
TABLE 138 US: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2024–2031 (USD MILLION) 208
TABLE 139 US: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2024–2031 (USD MILLION) 209
TABLE 140 US: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 209
TABLE 141 US: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 210
TABLE 142 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 210
TABLE 143 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 211
TABLE 144 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 211
TABLE 145 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 212
TABLE 146 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 212
TABLE 147 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 212
TABLE 148 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 213
TABLE 149 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 213
TABLE 150 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 214
TABLE 151 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 214
TABLE 152 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,
2024–2031 (USD MILLION) 215
TABLE 153 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2024–2031 (USD MILLION) 215
TABLE 154 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 216
TABLE 155 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 216
TABLE 156 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 217
TABLE 157 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 217
TABLE 158 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 217
TABLE 159 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 218
TABLE 160 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 218
TABLE 161 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 219
TABLE 162 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 219
TABLE 163 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 219
TABLE 164 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 220
TABLE 165 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 220
TABLE 166 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 221
TABLE 167 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,
2024–2031 (USD MILLION) 221
TABLE 168 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2024–2031 (USD MILLION) 222
TABLE 169 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 222
TABLE 170 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 171 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 223
TABLE 172 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE,
2024–2031 (USD MILLION) 224
TABLE 173 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 224
TABLE 174 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 225
TABLE 175 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 225
TABLE 176 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 225
TABLE 177 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 226
TABLE 178 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 226
TABLE 179 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 227
TABLE 180 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 227
TABLE 181 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,
2024–2031 (USD MILLION) 228
TABLE 182 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2024–2031 (USD MILLION) 228
TABLE 183 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 229
TABLE 184 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 229
TABLE 185 UK: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 230
TABLE 186 UK: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 230
TABLE 187 UK: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 231
TABLE 188 UK: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE, BY MODALITY,
2024–2031 (USD MILLION) 231
TABLE 189 UK: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE, BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 232
TABLE 190 UK: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE, BY TYPE,
2024–2031 (USD MILLION) 232
TABLE 191 UK: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 232
TABLE 192 UK: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 233
TABLE 193 UK: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 233
TABLE 194 UK: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 234
TABLE 195 UK: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2024–2031 (USD MILLION) 234
TABLE 196 UK: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2024–2031 (USD MILLION) 235
TABLE 197 UK: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 235
TABLE 198 UK: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 236
TABLE 199 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 236
TABLE 200 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 237
TABLE 201 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 237
TABLE 202 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 238
TABLE 203 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 238
TABLE 204 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 238
TABLE 205 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 239
TABLE 206 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 239
TABLE 207 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 240
TABLE 208 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 240
TABLE 209 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,
2024–2031 (USD MILLION) 241
TABLE 210 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2024–2031 (USD MILLION) 241
TABLE 211 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 242
TABLE 212 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 242
TABLE 213 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 243
TABLE 214 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 243
TABLE 215 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 244
TABLE 216 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 244
TABLE 217 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 245
TABLE 218 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 245
TABLE 219 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 245
TABLE 220 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 246
TABLE 221 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 246
TABLE 222 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 223 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,
2024–2031 (USD MILLION) 247
TABLE 224 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2024–2031 (USD MILLION) 248
TABLE 225 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 248
TABLE 226 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 227 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 249
TABLE 228 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 229 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 230 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 251
TABLE 231 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 251
TABLE 232 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 251
TABLE 233 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 252
TABLE 234 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 252
TABLE 235 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 253
TABLE 236 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 253
TABLE 237 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,
2024–2031 (USD MILLION) 254
TABLE 238 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2024–2031 (USD MILLION) 254
TABLE 239 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 255
TABLE 240 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 255
TABLE 241 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 256
TABLE 242 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 256
TABLE 243 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 257
TABLE 244 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 257
TABLE 245 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 258
TABLE 246 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 258
TABLE 247 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 258
TABLE 248 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 259
TABLE 249 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 259
TABLE 250 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 260
TABLE 251 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,
2024–2031 (USD MILLION) 260
TABLE 252 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2024–2031 (USD MILLION) 261
TABLE 253 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 261
TABLE 254 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 262
TABLE 255 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 263
TABLE 256 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 264
TABLE 257 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 264
TABLE 258 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 265
TABLE 259 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 265
TABLE 260 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 266
TABLE 261 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 266
TABLE 262 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 266
TABLE 263 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 267
TABLE 264 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 267
TABLE 265 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 268
TABLE 266 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,
2024–2031 (USD MILLION) 268
TABLE 267 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2024–2031 (USD MILLION) 269
TABLE 268 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 269
TABLE 269 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 270
TABLE 270 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 270
TABLE 271 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 271
TABLE 272 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 271
TABLE 273 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 272
TABLE 274 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 272
TABLE 275 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 272
TABLE 276 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 273
TABLE 277 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 273
TABLE 278 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 274
TABLE 279 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 274
TABLE 280 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,
2024–2031 (USD MILLION) 275
TABLE 281 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2024–2031 (USD MILLION) 275
TABLE 282 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 276
TABLE 283 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 276
TABLE 284 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 277
TABLE 285 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 277
TABLE 286 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 278
TABLE 287 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE, BY MODALITY,
2024–2031 (USD MILLION) 278
TABLE 288 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 279
TABLE 289 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 279
TABLE 290 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 279
TABLE 291 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 280
TABLE 292 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 280
TABLE 293 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 281
TABLE 294 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,
2024–2031 (USD MILLION) 281
TABLE 295 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2024–2031 (USD MILLION) 282
TABLE 296 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 282
TABLE 297 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 283
TABLE 298 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 283
TABLE 299 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 284
TABLE 300 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 284
TABLE 301 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE, BY MODALITY,
2024–2031 (USD MILLION) 285
TABLE 302 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 285
TABLE 303 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 285
TABLE 304 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 286
TABLE 305 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 286
TABLE 306 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 287
TABLE 307 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 287
TABLE 308 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,
2024–2031 (USD MILLION) 288
TABLE 309 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2024–2031 (USD MILLION) 288
TABLE 310 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 289
TABLE 311 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 289
TABLE 312 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 290
TABLE 313 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 290
TABLE 314 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 291
TABLE 315 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 291
TABLE 316 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 292
TABLE 317 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 292
TABLE 318 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 292
TABLE 319 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 293
TABLE 320 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 293
TABLE 321 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 294
TABLE 322 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,
2024–2031 (USD MILLION) 294
TABLE 323 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2024–2031 (USD MILLION) 295
TABLE 324 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 295
TABLE 325 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 296
TABLE 326 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 296
TABLE 327 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 297
TABLE 328 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 297
TABLE 329 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 298
TABLE 330 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 298
TABLE 331 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 298
TABLE 332 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 299
TABLE 333 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET,
BY FUNCTION, 2024–2031 (USD MILLION) 299
TABLE 334 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 300
TABLE 335 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 300
TABLE 336 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET,
BY AGE GROUP, 2024–2031 (USD MILLION) 301
TABLE 337 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET,
BY END USER, 2024–2031 (USD MILLION) 301
TABLE 338 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 302
TABLE 339 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 302
TABLE 340 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 303
TABLE 341 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 303
TABLE 342 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 304
TABLE 343 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 304
TABLE 344 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 305
TABLE 345 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 305
TABLE 346 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 305
TABLE 347 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 306
TABLE 348 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 306
TABLE 349 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 307
TABLE 350 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 307
TABLE 351 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,
2024–2031 (USD MILLION) 308
TABLE 352 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2024–2031 (USD MILLION) 308
TABLE 353 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 309
TABLE 354 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 309
TABLE 355 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 310
TABLE 356 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 311
TABLE 357 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 311
TABLE 358 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 312
TABLE 359 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 312
TABLE 360 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 312
TABLE 361 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 313
TABLE 362 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 313
TABLE 363 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 314
TABLE 364 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 314
TABLE 365 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,
2024–2031 (USD MILLION) 315
TABLE 366 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2024–2031 (USD MILLION) 315
TABLE 367 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 316
TABLE 368 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 316
TABLE 369 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 317
TABLE 370 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 317
TABLE 371 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES,
BY TYPE, 2024–2031 (USD MILLION) 318
TABLE 372 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 318
TABLE 373 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 319
TABLE 374 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 319
TABLE 375 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 319
TABLE 376 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 320
TABLE 377 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 320
TABLE 378 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 321
TABLE 379 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,
2024–2031 (USD MILLION) 321
TABLE 380 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2024–2031 (USD MILLION) 322
TABLE 381 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 322
TABLE 382 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 323
TABLE 383 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET,
BY COMPONENT, 2024–2031 (USD MILLION) 323
TABLE 384 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 324
TABLE 385 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 324
TABLE 386 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 325
TABLE 387 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 325
TABLE 388 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 325
TABLE 389 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 326
TABLE 390 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET,
BY FUNCTION, 2024–2031 (USD MILLION) 326
TABLE 391 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 327
TABLE 392 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET
FOR SPECIALTY CARE, BY TYPE, 2024–2031 (USD MILLION) 327
TABLE 393 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET,
BY AGE GROUP, 2024–2031 (USD MILLION) 328
TABLE 394 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET,
BY END USER, 2024–2031 (USD MILLION) 328
TABLE 395 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 329
TABLE 396 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 329
TABLE 397 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 330
TABLE 398 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET,
BY COMPONENT, 2024–2031 (USD MILLION) 330
TABLE 399 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 330
TABLE 400 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 331
TABLE 401 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 331
TABLE 402 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 332
TABLE 403 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 332
TABLE 404 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 332
TABLE 405 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET,
BY FUNCTION, 2024–2031 (USD MILLION) 333
TABLE 406 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 333
TABLE 407 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2024–2031 (USD MILLION) 334
TABLE 408 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET,
BY AGE GROUP, 2024–2031 (USD MILLION) 334
TABLE 409 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET,
BY END USER, 2024–2031 (USD MILLION) 335
TABLE 410 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 335
TABLE 411 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 336
TABLE 412 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET,
BY COMPONENT, 2024–2031 (USD MILLION) 336
TABLE 413 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE,
BY TYPE, 2024–2031 (USD MILLION) 337
TABLE 414 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 337
TABLE 415 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY MODALITY, 2024–2031 (USD MILLION) 338
TABLE 416 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 338
TABLE 417 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY TYPE, 2024–2031 (USD MILLION) 338
TABLE 418 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 339
TABLE 419 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET,
BY FUNCTION, 2024–2031 (USD MILLION) 339
TABLE 420 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 340
TABLE 421 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE,
BY TYPE, 2024–2031 (USD MILLION) 340
TABLE 422 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP,
2024–2031 (USD MILLION) 341
TABLE 423 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2024–2031 (USD MILLION) 341
TABLE 424 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 342
TABLE 425 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 342
TABLE 426 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET,
BY COMPONENT, 2024–2031 (USD MILLION) 343
TABLE 427 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION) 343
TABLE 428 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2024–2031 (USD MILLION) 344
TABLE 429 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET
FOR SOFTWARE, BY MODALITY, 2024–2031 (USD MILLION) 344
TABLE 430 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET
FOR SOFTWARE, BY INTEGRATION TYPE, 2024–2031 (USD MILLION) 345
TABLE 431 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET
FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION) 345
TABLE 432 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET
FOR SOFTWARE, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 345
TABLE 433 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET,
BY FUNCTION, 2024–2031 (USD MILLION) 346
TABLE 434 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 346
TABLE 435 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET
FOR SPECIALTY CARE, BY TYPE, 2024–2031 (USD MILLION) 347
TABLE 436 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET,
BY AGE GROUP, 2024–2031 (USD MILLION) 347
TABLE 437 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET,
BY END USER, 2024–2031 (USD MILLION) 348
TABLE 438 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET
FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 348
TABLE 439 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET
FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 349
TABLE 440 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN TELEHEALTH
AND TELEMEDICINE MARKET, JANUARY 2023–JULY 2026 351
TABLE 441 TELEHEALTH & TELEMEDICINE MARKET: DEGREE OF COMPETITION 357
TABLE 442 TELEHEALTH & TELEMEDICINE MARKET: REGION FOOTPRINT 363
TABLE 443 TELEHEALTH & TELEMEDICINE MARKET: FUNCTION FOOTPRINT 364
TABLE 444 TELEHEALTH & TELEMEDICINE MARKET: APPLICATION FOOTPRINT 365
TABLE 445 TELEHEALTH & TELEMEDICINE MARKET: COMPONENT FOOTPRINT 366
TABLE 446 TELEHEALTH & TELEMEDICINE MARKET: END USER FOOTPRINT 367
TABLE 447 TELEHEALTH & TELEMEDICINE MARKET: DETAILED LIST OF KEY STARTUPS/SMES 370
TABLE 448 TELEHEALTH & TELEMEDICINE MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 370
TABLE 449 TELEHEALTH & TELEMEDICINE MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–JULY 2026 372
TABLE 450 TELEHEALTH & TELEMEDICINE MARKET: DEALS, JANUARY 2023–JULY 2026 373
TABLE 451 TELEHEALTH & TELEMEDICINE MARKET: EXPANSIONS, JANUARY 2023–JULY 2026 374
TABLE 452 TELEHEALTH & TELEMEDICINE MARKET: OTHER DEVELOPMENTS,
JANUARY 2023–JULY 2026 375
TABLE 453 MEDTRONIC: COMPANY OVERVIEW 376
TABLE 454 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 378
TABLE 455 MEDTRONIC: PRODUCT LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026 380
TABLE 456 MEDTRONIC: DEALS, JANUARY 2023–JULY 2026 380
TABLE 457 TELADOC HEALTH, INC.: COMPANY OVERVIEW 382
TABLE 458 TELADOC HEALTH, INC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 384
TABLE 459 TELADOC HEALTH, INC.: PRODUCT LAUNCHES AND ENHANCEMENTS,
JANUARY 2023–JULY 2026 385
TABLE 460 TELADOC HEALTH, INC.: DEALS, JANUARY 2023–JULY 2026 386
TABLE 461 CISCO SYSTEMS, INC.: COMPANY OVERVIEW 388
TABLE 462 CISCO SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 390
TABLE 463 CISCO SYSTEMS, INC.: DEALS, JANUARY 2023–JULY 2026 391
TABLE 464 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 392
TABLE 465 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 394
TABLE 466 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–JULY 2026 396
TABLE 467 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023–JULY 2026 397
TABLE 468 ZOOM COMMUNICATIONS, INC.: COMPANY OVERVIEW 399
TABLE 469 ZOOM COMMUNICATIONS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 400
TABLE 470 ZOOM COMMUNICATIONS, INC.: DEALS, JANUARY 2023–JULY 2026 400
TABLE 471 GE HEALTHCARE: COMPANY OVERVIEW 403
TABLE 472 GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 405
TABLE 473 GE HEALTHCARE: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 406
TABLE 474 GE HEALTHCARE: DEALS, JANUARY 2023–JULY 2026 406
TABLE 475 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 407
TABLE 476 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 408
TABLE 477 EPIC SYSTEMS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 408
TABLE 478 EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES AND ENHANCEMENTS,
JANUARY 2023–JULY 2026 410
TABLE 479 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2023–JULY 2026 411
TABLE 480 ORACLE: COMPANY OVERVIEW 412
TABLE 481 ORACLE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 414
TABLE 482 ORACLE: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 415
TABLE 483 ORACLE: DEALS, JANUARY 2023–JULY 2026 416
TABLE 484 DOXIMITY, INC.: COMPANY OVERVIEW 418
TABLE 485 DOXIMITY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 419
TABLE 486 DOXIMITY, INC.: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 420
TABLE 487 DOXIMITY, INC.: DEALS, JANUARY 2023–JULY 2026 420
TABLE 488 DOXIMITY, INC.: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 421
TABLE 489 AMERICAN WELL: COMPANY OVERVIEW 422
TABLE 490 AMERICAN WELL: PRODUCTS/SERVICES/SOLUTIONS OFFERED 423
TABLE 491 AMERICAN WELL: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 424
TABLE 492 AMERICAN WELL: DEALS, JANUARY 2023–JULY 2026 424
TABLE 493 AMERICAN WELL: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 425
TABLE 494 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 426
TABLE 495 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 428
TABLE 496 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 429
TABLE 497 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2023–JULY 2026 429
TABLE 498 INCLUDED HEALTH, INC.: COMPANY OVERVIEW 431
TABLE 499 INCLUDED HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 432
TABLE 500 INCLUDED HEALTH, INC.: DEALS, JANUARY 2023–JULY 2026 432
TABLE 501 INCLUDED HEALTH, INC.: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 434
TABLE 502 AMC HEALTH: COMPANY OVERVIEW 435
TABLE 503 AMC HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 435
TABLE 504 AMC HEALTH.: DEALS, JANUARY 2023–JULY 2026 436
TABLE 505 TELESPECIALISTS: COMPANY OVERVIEW 437
TABLE 506 TELESPECIALISTS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 437
TABLE 507 TELESPECIALISTS: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 438
TABLE 508 TELESPECIALISTS: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 438
TABLE 509 WALGREENS BOOTS ALLIANCE (WALGREEN CO.): COMPANY OVERVIEW 439
TABLE 510 WALGREENS BOOTS ALLIANCE (WALGREEN CO.): PRODUCTS/SERVICES/
SOLUTIONS OFFERED 440
TABLE 511 WALGREENS BOOTS ALLIANCE (WALGREEN CO.): PRODUCT LAUNCHES,
JANUARY 2023–JULY 2026 440
TABLE 512 WALGREENS BOOTS ALLIANCE (WALGREEN CO.): DEALS, JANUARY 2023–JULY 2026 440
TABLE 513 WALGREENS BOOTS ALLIANCE (WALGREEN CO.): EXPANSIONS,
JANUARY 2023–JULY 2026 441
TABLE 514 WALGREENS BOOTS ALLIANCE (WALGREEN CO.): OTHER DEVELOPMENTS,
JANUARY 2023–JULY 2026 441
TABLE 515 CAREGILITY: COMPANY OVERVIEW 442
TABLE 516 CAREGILITY: PRODUCTS/SERVICES OFFERED 442
TABLE 517 CAREGILITY: DEALS, JANUARY 2023–JULY 2026 443
TABLE 518 CVS HEALTH: COMPANY OVERVIEW 444
TABLE 519 CVS HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 445
TABLE 520 CVS HEALTH: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 445
TABLE 521 CVS HEALTH: DEALS, JANUARY 2023–JULY 2026 446
TABLE 522 EVERNORTH HEALTH, INC.: COMPANY OVERVIEW 447
TABLE 523 EVERNORTH HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 449
TABLE 524 EVERNORTH HEALTH, INC.: DEALS, JANUARY 2023–JULY 2026 449
TABLE 525 ELATION: COMPANY OVERVIEW 450
TABLE 526 ELATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 450
TABLE 527 ELATION: DEALS, JANUARY 2023–JULY 2026 450
TABLE 528 IRON BOW TECHNOLOGIES: COMPANY OVERVIEW 451
TABLE 529 IRON BOW TECHNOLOGIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 452
TABLE 530 TIMEDOC, INC.: COMPANY OVERVIEW 453
TABLE 531 CEREBRAL INC.: COMPANY OVERVIEW 454
TABLE 532 KINDBODY: COMPANY OVERVIEW 455
TABLE 533 TRANSACARENT: COMPANY OVERVIEW 456
TABLE 534 CARESIMPLE INC.: COMPANY OVERVIEW 457
LIST OF FIGURES
FIGURE 1 TELEHEALTH & TELEMEDICINE MARKET SEGMENTATION & REGIONAL SCOPE 41
FIGURE 2 MARKET SCENARIO 46
FIGURE 3 GLOBAL TELEHEALTH AND TELEMEDICINE MARKET, 2024–2031 47
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN TELEHEALTH AND
TELEMEDICINE MARKET, 2024–2026 47
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF TELEHEALTH AND TELEMEDICINE MARKET 48
FIGURE 6 HIGH-GROWTH SEGMENTS IN TELEHEALTH AND TELEMEDICINE MARKET, 2026–2031 49
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN TELEHEALTH AND TELEMEDICINE MARKET DURING FORECAST PERIOD 50
FIGURE 8 NEED TO IMPROVE ACCESSIBILITY AND REDUCE HEALTHCARE EXPENSES
TO DRIVE GROWTH IN TELEHEALTH & TELEMEDICINE MARKET 52
FIGURE 9 HEALTHCARE PROVIDERS IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 53
FIGURE 10 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 54
FIGURE 11 TELEHEALTH & TELEMEDICINE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 55
FIGURE 12 US: MEDICARE-CERTIFIED AMBULATORY SURGERY CENTERS,
BY STATE (SEPTEMBER 2024) 64
FIGURE 13 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009–2024 67
FIGURE 14 US: MEDIAN HEALTHCARE DATA BREACH SIZE, 2009–2024 67
FIGURE 15 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009–2023 68
FIGURE 16 TELEHEALTH & TELEMEDICINE MARKET: PORTER’S FIVE FORCES ANALYSIS 73
FIGURE 17 TELEHEALTH & TELEMEDICINE MARKET: VALUE CHAIN ANALYSIS 78
FIGURE 18 TELEHEALTH & TELEMEDICINE MARKET: ECOSYSTEM ANALYSIS 79
FIGURE 19 TELEHEALTH & TELEMEDICINE MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 84
FIGURE 20 FUNDING AND DEALS IN TELEHEALTH & TELEMEDICINE MARKET 85
FIGURE 21 GLOBAL PATENT PUBLICATION TRENDS IN TELEHEALTH & TELEMEDICINE, 2015–2026 100
FIGURE 22 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR TELEHEALTH & TELEMEDICINE (JANUARY 2015–SEPTEMBER 2026) 101
FIGURE 23 POTENTIAL OF AI/GEN AI IN TELEHEALTH & TELEMEDICINE MARKET 105
FIGURE 24 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 118
FIGURE 25 KEY BUYING CRITERIA FOR TOP THREE COMPONENTS 119
FIGURE 26 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT 196
FIGURE 27 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT 263
FIGURE 28 TELEHEALTH AND TELEMEDICINE MARKET: REVENUE ANALYSIS OF
KEY PLAYERS, 2021–2025 (USD MILLION) 355
FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS IN TELEHEALTH AND TELEMEDICINE MARKET, 2025 356
FIGURE 30 EV/EBITDA OF KEY VENDORS 359
FIGURE 31 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 359
FIGURE 32 TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 361
FIGURE 33 TELEHEALTH & TELEMEDICINE MARKET: COMPANY FOOTPRINT 362
FIGURE 34 TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 369
FIGURE 35 TELEHEALTH & TELEMEDICINE MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 371
FIGURE 36 MEDTRONIC: COMPANY SNAPSHOT 377
FIGURE 37 TELADOC HEALTH, INC.: COMPANY SNAPSHOT 383
FIGURE 38 CISCO SYSTEMS, INC.: COMPANY SNAPSHOT 389
FIGURE 39 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 393
FIGURE 40 ZOOM COMMUNICATIONS, INC.: COMPANY SNAPSHOT 399
FIGURE 41 GE HEALTHCARE: COMPANY SNAPSHOT 404
FIGURE 42 ORACLE: COMPANY SNAPSHOT 413
FIGURE 43 DOXIMITY, INC.: COMPANY SNAPSHOT 418
FIGURE 44 AMERICAN WELL: COMPANY SNAPSHOT 422
FIGURE 45 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 427
FIGURE 46 WALGREENS BOOTS ALLIANCE (WALGREEN CO.): COMPANY SNAPSHOT 439
FIGURE 47 CVS HEALTH: COMPANY SNAPSHOT 444
FIGURE 48 EVERNORTH HEALTH, INC.: COMPANY SNAPSHOT 448
FIGURE 49 RESEARCH DESIGN 458
FIGURE 50 PRIMARY SOURCES 460
FIGURE 51 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 462
FIGURE 52 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 463
FIGURE 53 TOP-DOWN APPROACH 464
FIGURE 54 CAGR PROJECTIONS, 2026–2031 465
FIGURE 55 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 466
FIGURE 56 DATA TRIANGULATION 467
